Gene · 10312
Papers2,533
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,533
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis of RNA conformational switching in the transcriptional regulator 7SK RNP. | Mol Cell | 2022 | 35320752 | PubTator, text mining | PubMed |
| Open-Label Pilot Study of Interferon Gamma-1b in Patients With Non-Infantile Osteopetrosis. | JBMR Plus | 2022 | 35309862 | PubTator, text mining | PubMed |
| Human Retinal Organoids Provide a Suitable Tool for Toxicological Investigations: A Comprehensive Validation Using Drugs and Compounds Affecting the Retina. | Stem Cells Transl Med | 2022 | 35298655 | PubTator, text mining | PubMed |
| Low-Temperature Adaptation Targets Genome Packing Reactions in an Icosahedral Single-Stranded DNA Virus. | J Virol | 2022 | 35285686 | PubTator, text mining | PubMed |
| Properties, Genetics and Innate Immune Function of the Cuticle in Egg-Laying Species. | Front Immunol | 2022 | 35281050 | PubTator, text mining | PubMed |
| HLA-G and the MHC Cusp Theory. | Front Immunol | 2022 | 35281038 | PubTator, text mining | PubMed |
A Systematic Comparative Assessment of the Response of Ovarian Cancer Cells to the Chemotherapeutic Cisplatin in 3D Models of Various Structural and Biochemical Configurations-Does One Model Type Fit All? | Cancers (Basel) | 2022 | 35267582 | PubTator, text mining | PubMed |
| Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations. | Cell Cycle | 2022 | 35266851 | PubTator, text mining | PubMed |
| Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer. | Front Cell Dev Biol | 2022 | 35265613 | PubTator, text mining | PubMed |
| Inhibition of the proliferation, invasion, migration, and epithelial-mesenchymal transition of prostate cancer cells through the action of ATP1A2 on the TGF-β/Smad pathway. | Transl Androl Urol | 2022 | 35242641 | PubTator, text mining | PubMed |
| Abundant expression of ferroptosis-related SAT1 is related to unfavorable outcome and immune cell infiltration in low-grade glioma. | BMC Cancer | 2022 | 35227235 | PubTator, text mining | PubMed |
| Understanding the Molecular Basis of Fragile X Syndrome Using Differentiated Mesenchymal Stem Cells. | Iran J Child Neurol | 2022 | 35222660 | PubTator, text mining | PubMed |
| A Novel 16-Genes Signature Scoring System as Prognostic Model to Evaluate Survival Risk in Patients with Glioblastoma. | Biomedicines | 2022 | 35203526 | PubTator, text mining | PubMed |
| A Novel α4/7-Conotoxin QuIA Selectively Inhibits α3β2 and α6/α3β4 Nicotinic Acetylcholine Receptor Subtypes with High Efficacy. | Mar Drugs | 2022 | 35200675 | PubTator, text mining | PubMed |
| A Bayesian hierarchical model for individual participant data meta-analysis of demand curves. | Stat Med | 2022 | 35194829 | PubTator, text mining | PubMed |
| Effects of gestational exposure to bisphenol A on the hepatic transcriptome and lipidome of rat dams: Intergenerational comparison of effects in the offspring. | Sci Total Environ | 2022 | 35192832 | PubTator, text mining | PubMed |
| Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases. | Int J Mol Sci | 2022 | 35163424 | PubTator, text mining | PubMed |
| Hematopoietic Cells from Pluripotent Stem Cells: Hope and Promise for the Treatment of Inherited Blood Disorders. | Cells | 2022 | 35159366 | PubTator, text mining | PubMed |
| Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer. | Cancers (Basel) | 2022 | 35158766 | PubTator, text mining | PubMed |
| Application of Porcine Kidney-Derived Extracellular Matrix as Coating, Hydrogel, and Scaffold Material for Renal Proximal Tubular Epithelial Cell. | Biomed Res Int | 2022 | 35127940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10312/papers?page=18